VIDEO: Evidence suggests it is safe to use preoperative biologics in IBD patients

DENVER — In a Healio video exclusive, Stefan D. Holubar, MD, MS, discusses the decades-long controversy surrounding preoperative use of biologics and risk for postoperative complications in patients with inflammatory bowel disease.According to Holubar, IBD surgery section chief and the director of research for the department of colorectal surgery at Cleveland Clinic, analysis of data from the PUCCINI trial and National Surgical Quality Improvement Program (NSQIP)-IBD Collaborative showed no association between preoperative biologic exposure and postoperative complications, infectiousRead More

Generated by Feedzy